566 filings
20-F
2022 FY
CASI
CASI Pharmaceuticals Inc
26 Apr 23
Annual report (foreign)
8:25am
EFFECT
CASI
CASI Pharmaceuticals Inc
27 Mar 23
Notice of effectiveness
12:15am
15-12G
CASI
CASI Pharmaceuticals Inc
22 Mar 23
Securities registration termination
6:00am
S-8 POS
CASI
CASI Pharmaceuticals Inc
21 Mar 23
Registration of securities for employees (post-effective amendment)
5:07pm
S-8 POS
CASI
CASI Pharmaceuticals Inc
21 Mar 23
Registration of securities for employees (post-effective amendment)
5:04pm
S-8 POS
qgriv3vm l7dn
21 Mar 23
Registration of securities for employees (post-effective amendment)
5:02pm
S-8 POS
aizo01jo
21 Mar 23
Registration of securities for employees (post-effective amendment)
4:59pm
POS AM
ca0 gjhyxvcauo2wlm
21 Mar 23
Prospectus update (post-effective amendment)
4:50pm
8-K
cxr7gi0
21 Mar 23
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
o71zogzx
31 Jan 23
Entry into a Material Definitive Agreement
4:01pm
UPLOAD
fbr46sasub uuhy9be
30 Jan 23
Letter from SEC
12:00am
CORRESP
4jeid8 yfuu9l4msy
19 Jan 23
Correspondence with SEC
12:00am
UPLOAD
grb z78pjz
6 Jan 23
Letter from SEC
12:00am
CORRESP
h9lud vut51uw5t
16 Dec 22
Correspondence with SEC
12:00am
UPLOAD
k5si52y 0rk3
7 Dec 22
Letter from SEC
12:00am
8-K
z06zb
14 Nov 22
Casi Pharmaceuticals Announces Third Quarter 2022 Financial Results
4:00pm
8-K
28ztt90nth
23 Sep 22
Casi Pharmaceuticals Announces Exit of Juventas Investment to Strengthen Balance Sheet
4:02pm
8-K
v2xd gs7d
12 Aug 22
Casi Pharmaceuticals Announces Second Quarter 2022 Financial Results
4:01pm